v3.26.1
Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 17,487 $ 22,814
General and administrative 4,083 7,071
Total operating expenses 21,570 29,885
Loss from operations (21,570) (29,885)
Interest income 1,342 1,683
Interest expense (23) 0
Other expense, net 7 (12)
Loss before income tax provision (20,244) (28,214)
Income tax provision 0 0
Segment net loss $ (20,244) $ (28,214)
Net loss per share, basic $ (1.88) $ (4.96)
Net loss per share, diluted $ (1.88) $ (4.96)
Weighted-average common shares used in computing net loss per share, basic 10,744,621 5,691,965
Weighted-average common shares used in computing net loss per share, diluted 10,744,621 5,691,965
Other comprehensive income    
Unrealized gain on treasury securities, net of tax $ (139) $ (25)
Total other comprehensive income (139) (25)
Comprehensive loss $ (20,383) $ (28,239)